Phase II study of carbetimer in non-small cell lung cancer

Invest New Drugs. 1990 Nov;8(4):385-6. doi: 10.1007/BF00198596.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Evaluation
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Polymers / adverse effects
  • Polymers / therapeutic use*

Substances

  • Antineoplastic Agents
  • Drugs, Investigational
  • Polymers
  • carboxyimamidate